Viability analysis and apoptosis induction of breast cancer cells in a microfluidic device: effect of cytostatic drugs
Authors:
Open Access
- 4 June 2008
- journal article
- research article
- Published by Springer Nature in Biomedical Microdevices
- Vol. 10 (5) , 727-737
Abstract
Breast cancer is the leading cause of cancer deaths among non-smoking women worldwide. At the moment the treatment regime is such that patients receive different chemotherapeutic and/or hormonal treatments dependent on the hormone receptor status, the menopausal status and age. However, in vitro sensitivity testing of tumor biopsies could rationalize and improve the choice of chemo- and hormone therapy. Lab-on-a-Chip devices, using microfluidic techniques, make detailed cellular analysis possible using fewer cells, enabling working with a patients’ own cells and performing chemo- and hormone sensitivity testing in an ex vivo setting. This article describes the development of two microfluidic devices made in poly(dimethylsiloxane) (PDMS) to validate the cell culture properties and analyze the chemosensitivity of MCF-7 cells (estrogen receptor positive human breast cancer cells) in response to the drug staurosporine (SSP). In both cases, cell viability was assessed using the life-stain Calcein-AM (CAAM) and the death dye propidium iodide (PI). MCF-7 cells could be statically cultured for up to 7 days in the microfluidic chip. A 30 min flow with SSP and a subsequent 24 h static incubation in the incubator induced apoptosis in MCF-7 cells, as shown by a disappearance of the aggregate-like morphology, a decrease in CAAM staining and an increase in PI staining. This work provides valuable leads to develop a microfluidic chip to test the chemosensitivity of tumor cells in response to therapeutics and in this way improve cancer treatment towards personalized medicine.Keywords
This publication has 45 references indexed in Scilit:
- Integrated microfluidic cell culture and lysis on a chipLab on a Chip, 2007
- Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesisNature Reviews Cancer, 2007
- HER-2 therapy. HER-2/neu diagnostics in breast cancerBreast Cancer Research, 2007
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancerAnti-Cancer Drugs, 2005
- Continuous perfusion microfluidic cell culture array for high‐throughput cell‐based assaysBiotechnology and Bioengineering, 2004
- Microtechnologies and nanotechnologies for single-cell analysisCurrent Opinion in Biotechnology, 2004
- Cytometric analysis of protein expression and apoptosis in human primary cells with a novel microfluidic chip‐based systemCytometry Part A, 2003
- Microfluidic devices for cellomics: a reviewSensors and Actuators B: Chemical, 2003
- The effect of continuous combined 17β-oestradiol and dihydrodydrogesterone on apoptotic cell death and proliferation of human breast cancer cells in vitroEuropean Journal of Cancer, 2002